Aimmune Therapeutics, Inc. ishicilela nini isitatimende senzuzo nokulahlekelwa?
I-Aimmune Therapeutics, Inc. isitatimende senzuzo nokulahlekelwa yashicilelwa kanye nekota, isitatimende sezimali samuva se-Aimmune Therapeutics, Inc. sanyatheliswa ngo-30/09/2019.
Iyini inzuzo kusuka kwamasheya e Aimmune Therapeutics, Inc.?
Inani elilinganiselwayo lemali engenayo ye-Aimmune Therapeutics, Inc. laliyi--1.03 $ embikweni wokugcina wezezimali.
I-Aimmune Therapeutics, Inc. izokhipha nini isitatimende esilandelayo senzuzo nokulahlekelwa?
Umbiko olandelayo mayelana ne-akhawunti ye-profit and loss Aimmune Therapeutics, Inc. izoba ngo-December 2024.
Aimmune Therapeutics, Inc. imali etholwa ngengxenye ngayinye yenkampani - enye yezinkomba zokuhola kwemali yenkampani kusuka ngosayizi wenani layo. Umholo ngenzuzo ngayinye ubalwa kalula - yonke inzuzo yenkampani yesikhathi sokubika sezezimali esihlukaniswe ngenombolo yamasheya. Aimmune Therapeutics, Inc. ngesabelo ngasinye sibalwa isikhathi sokuphumula ngasinye sezezimali. Inzuzo ye- Aimmune Therapeutics, Inc. - inzuzo ephelele yesikhathi sezimali sokubika.
|
Inzuzo Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. inzuzo ephelele isethenjwa kuphela futhi ayithokozisi kwabaninimasheya ngamunye. Okubaluleke kakhulu ukubalwa kwemali etholwayo ngesabelo ngasinye. Leli nani liyisisekelo sokubala izabelo futhi kungaphezulu kwesidingo ngokunakwa kwabahlanganyeli. Usuku lombiko wenzuzo Aimmune Therapeutics, Inc. iboshelwe emthethweni wezwe wokubhaliswa kwale nkampani. Usuku ngalunye lwesitatimende senzuzo se- Aimmune Therapeutics, Inc. isitatimende senzuzo sihambelana nomugqa wethebula lesevisi.
|
Inzuzo ngekota Aimmune Therapeutics, Inc.
Imali etholwayo ngesabelo ngasinye Aimmune Therapeutics, Inc. ibalwa ngokuya ngefomula: imali engenayo ihlukaniswe ngenani lamasheya enkampanini. Imali etholwayo ngesabelo ngasinye se- Aimmune Therapeutics, Inc. kunqunywa isikhathi sezimali esinqunyelwe futhi ihambelana nemiphumela yezitatimende zezezimalienzuzo yenkampani. Aimmune Therapeutics, Inc. ngesabelo ngasinye esikhathini sakamuva kakhulu kwigrafu kukholamu kwesokudla. Inzuzo yekota Aimmune Therapeutics, Inc. luhlobo oluphambili lwezitatimende zezezimali phakathi kwezinkampani.
|
|
AIMT usuku lokubika
|
Ukuzuza nge-share ngayinye
Imali ngayinye ezuzwa ibalwa ngokuhlukanisa imali engenayo (noma inzuzo) ngenani lamasheya enkampanini.
|
Shintsha unyaka %
|
|
30/09/2019 |
-1.03 USD |
-12.631% ↓ |
|
30/06/2019 |
-1.01 USD |
-8.754% ↓ |
|
31/03/2019 |
-0.87 USD |
-26.521% ↓ |
|
31/12/2018 |
-0.95 USD |
-19.67% ↓ |
|
30/09/2018 |
-0.89 USD |
-19.524% ↓ |
|
30/06/2018 |
-0.91 USD |
-25.313% ↓ |
|
31/03/2018 |
-0.92 USD |
-21.964% ↓ |
|
31/12/2017 |
-0.81 USD |
-35.431% ↓ |
|
30/09/2017 |
-0.63 USD |
-36.758% ↓ |
|
30/06/2017 |
-0.65 USD |
-35.79% ↓ |
|
31/03/2017 |
-0.52 USD |
-28.623% ↓ |
|
31/12/2016 |
-0.55 USD |
-26.625% ↓ |
|
30/09/2016 |
-0.53 USD |
-48.799% ↓ |
|
30/06/2016 |
-0.43 USD |
-31.928% ↓ |
|
31/03/2016 |
-0.31 USD |
- |
|
31/12/2015 |
-0.31 USD |
- |
|
30/09/2015 |
-0.36 USD |
- |
|
30/06/2015 |
-1.6 USD |
- |
Aimmune Therapeutics, Inc. imali etholwa ngekota ngesabelo ngasinye ngesinye sezinkomba zenzuzo yenhlangano, noma idume kancane kunenzuzo yonyaka ngesabelo ngasinye. Inzuzo yekota eledlule Aimmune Therapeutics, Inc. yanamuhla isho inzuzo eshicilelwe ngekota yokugcina ebekiwe. Ukushintshwa kwenzuzo Aimmune Therapeutics, Inc. yonyaka inani elibaliwe lemininingwane eyengeziwe ekhombisa ushintsho kumaphesenti wenzuzo ngokunqunyelwa okufanayo konyaka owedlule. Ukushintshwa kwe- Aimmune Therapeutics, Inc. inzuzo yekota yonyaka akubalulekanga kangako njengoba ushintsho ku- Aimmune Therapeutics, Inc. inzuzo yonyaka kuqhathaniswa nonyaka owedlule.
Amandla wenzuzo yenkampani akhonjiswa njengephesenti. Umlando wokwenza inzuzo we- Aimmune Therapeutics, Inc. yeminyaka edlule nezikhathi zokubika kusetafuleni elithi "Inzuzo yekota". Aimmune Therapeutics, Inc. umlando wokuthola imali ngekota iyatholakala online eminyakeni eyi-10 eyedlule. Imininingo egciniwe yenzuzo yanyakenye nezinye izinkathi Aimmune Therapeutics, Inc. ihlanganiswe emithonjeni yomphakathi.
|
